Cantex Pharmaceuticals
4 clinical trials · Sponsor
◉ Watch Cantex Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Azeliragon in MGMT Unmethylated Glioblastoma (NCT05986851) | Cantex Pharmaceuticals | 2023-09-12 |
| Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma (NCT05635734) | Cantex Pharmaceuticals | 2023-09-05 |
| Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer (NCT05766748) | Cantex Pharmaceuticals | 2023-06-01 |
| Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma (NCT03034135) | Cantex Pharmaceuticals | 2017-03-09 |
Track Cantex Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.